Cargando…
Prolonged survival by 'early' salvage treatment of breast cancer patients: a retrospective 6-year study.
Between 1977 and 1993, 384 breast cancer patients were followed up post-operatively every 4 or 6 months with a serum tumour marker panel (CEA-TPA-CA15-3) and the usual imaging techniques. Twenty-eight patients were treated 13.5 +/- 10 months (mean +/- s.d.) before the clinical and/or radiological oc...
Autores principales: | Nicolini, A., Anselmi, L., Michelassi, C., Carpi, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228104/ https://www.ncbi.nlm.nih.gov/pubmed/9376274 |
Ejemplares similares
-
Immune Checkpoint Inhibitors and Other Immune Therapies in Breast Cancer: A New Paradigm for Prolonged Adjuvant Immunotherapy
por: Nicolini, Andrea, et al.
Publicado: (2022) -
The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer
por: Nicolini, A, et al.
Publicado: (2000) -
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
por: Nicolini, Andrea, et al.
Publicado: (2006) -
The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy
por: Nicolini, A, et al.
Publicado: (1999) -
Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer
por: Nicolini, Andrea, et al.
Publicado: (2017)